Literature DB >> 18686011

Late gadolinium enhancement: precursor to cardiomyopathy in Duchenne muscular dystrophy?

Michael D Puchalski1, Richard V Williams, Bojana Askovich, C Todd Sower, Kan H Hor, Jason T Su, Nathan Pack, Edward Dibella, William M Gottliebson.   

Abstract

BACKGROUND: Progressive cardiomyopathy is a common cause of death in Duchenne muscular dystrophy (DMD), presumably secondary to fibrosis of the myocardium. The posterobasal and left lateral free wall of the left ventricle (LV) are initial sites of myocardial fibrosis pathologically. The purposes of this study were to assess whether cardiac magnetic resonance imaging (CMRI), utilizing late gadolinium enhancement (LGE), could identify fibrosis in selective areas of the myocardium, and to assess the relationship of the presence and extent of fibrosis to LV function.
METHODS: The cardiology databases at Primary Children's Medical Center and Cincinnati Children's Hospital Medical Center were reviewed to identify patients with DMD who had undergone a CMRI within the last 2 years. Age, LV ejection fraction, LV mass, presence and location of LGE were documented. Volumes were measured using MASS (Medis, Inc.) to calculate ejection fraction and mass. LGE images were acquired and when positive, customized computer assisted sizing of the areas of late gadolinium enhancement were performed on all slices. Normal function was defined as LV ejection fraction >54%.
RESULTS: A total of 74 patients with DMD had complete data sets (median age 13.7 years, range 7.7-26.4). Twenty-four patients (32%) had LGE involving the posterobasal region of the LV in a sub-epicardial distribution. Those patients with more involvement had spread to the inferior and left lateral free wall with progressive transmural fibrous replacement. There was relative sparing of the interventricular septum and right ventricle. Patients with LGE were significantly older than those without (mean age 16.4 vs 12.9 years, P < 0.001). LGE was positively associated with BSA-adjusted LV mass, LV end-diastolic volume, LV end-systolic volume, and RV end-systolic volume but inversely correlated with ejection fraction of the LV (P < 0.001) and RV (P = 0.004).
CONCLUSIONS: LGE by CMRI is able to detect fibrosis in selective regions of myocardium in patients with DMD. Unfavorable LV remodeling, with a corresponding decreased ejection fraction, is associated with the presence of LGE. Serial studies are warranted to determine if LGE precedes a decrease in function, and if early medical management is useful in preventing progression once LGE is documented.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18686011      PMCID: PMC2746925          DOI: 10.1007/s10554-008-9352-y

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  24 in total

1.  The incidence and evolution of cardiomyopathy in Duchenne muscular dystrophy.

Authors:  G Nigro; L I Comi; L Politano; R J Bain
Journal:  Int J Cardiol       Date:  1990-03       Impact factor: 4.164

Review 2.  The role of cytoskeletal proteins in cardiomyopathies.

Authors:  J A Towbin
Journal:  Curr Opin Cell Biol       Date:  1998-02       Impact factor: 8.382

3.  The pathology of the heart in progressive muscular dystrophy: epimyocardial fibrosis.

Authors:  K A Frankel; R J Rosser
Journal:  Hum Pathol       Date:  1976-07       Impact factor: 3.466

4.  Sequence of cardiac changes in Duchenne muscular dystrophy.

Authors:  S B Heymsfield; T McNish; J V Perkins; J M Felner
Journal:  Am Heart J       Date:  1978-03       Impact factor: 4.749

5.  Serial two-dimensional echocardiography in Duchenne muscular dystrophy.

Authors:  S J Goldberg; L Z Stern; L Feldman; H D Allen; D J Sahn; L M Valdes-Cruz
Journal:  Neurology       Date:  1982-10       Impact factor: 9.910

6.  Alterations in regional myocardial metabolism, perfusion, and wall motion in Duchenne muscular dystrophy studied by radionuclide imaging.

Authors:  J K Perloff; E Henze; H R Schelbert
Journal:  Circulation       Date:  1984-01       Impact factor: 29.690

7.  The heart in Duchenne muscular dystrophy: a non-invasive longitudinal study.

Authors:  E Bäckman; E Nylander
Journal:  Eur Heart J       Date:  1992-09       Impact factor: 29.983

8.  Prevalence of left ventricular systolic dysfunction in Duchenne muscular dystrophy: an echocardiographic study.

Authors:  J M de Kermadec; H M Bécane; A Chénard; F Tertrain; Y Weiss
Journal:  Am Heart J       Date:  1994-03       Impact factor: 4.749

9.  Discrepancy between systolic and diastolic dysfunction of the left ventricle in patients with Duchenne muscular dystrophy.

Authors:  A Takenaka; M Yokota; M Iwase; K Miyaguchi; H Hayashi; H Saito
Journal:  Eur Heart J       Date:  1993-05       Impact factor: 29.983

10.  Cardiac and respiratory involvement in advanced stage Duchenne muscular dystrophy.

Authors:  P Melacini; A Vianello; C Villanova; M Fanin; M Miorin; C Angelini; S Dalla Volta
Journal:  Neuromuscul Disord       Date:  1996-10       Impact factor: 4.296

View more
  66 in total

Review 1.  Utility of late gadolinium enhancement in pediatric cardiac MRI.

Authors:  Maryam Etesami; Robert C Gilkeson; Prabhakar Rajiah
Journal:  Pediatr Radiol       Date:  2015-12-30

2.  Early detection of cardiomyopathy in Duchenne muscular dystrophy, is there a role for MRI?

Authors:  Leo H B Baur
Journal:  Int J Cardiovasc Imaging       Date:  2008-10-15       Impact factor: 2.357

Review 3.  Identifying the etiology: a systematic approach using delayed-enhancement cardiovascular magnetic resonance.

Authors:  Annamalai Senthilkumar; Maulik D Majmudar; Chetan Shenoy; Han W Kim; Raymond J Kim
Journal:  Heart Fail Clin       Date:  2009-07       Impact factor: 3.179

4.  Duchenne muscular dystrophy; a cardiomyopathy that can be prevented?

Authors:  Barbara J M Mulder; Ernst E van der Wall
Journal:  Int J Cardiovasc Imaging       Date:  2008-10-01       Impact factor: 2.357

5.  Early right ventricular fibrosis and reduction in biventricular cardiac reserve in the dystrophin-deficient mdx heart.

Authors:  Tatyana A Meyers; DeWayne Townsend
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-12-05       Impact factor: 4.733

Review 6.  Cardiac imaging techniques for physicians: late enhancement.

Authors:  Peter Kellman; Andrew E Arai
Journal:  J Magn Reson Imaging       Date:  2012-09       Impact factor: 4.813

7.  Cardiac assessment of patients with late stage Duchenne muscular dystrophy.

Authors:  E A P van Bockel; J S Lind; J G Zijlstra; P J Wijkstra; P M Meijer; M P van den Berg; R H J A Slart; L P H J Aarts; J E Tulleken
Journal:  Neth Heart J       Date:  2009-06       Impact factor: 2.380

8.  Early manifestation of alteration in cardiac function in dystrophin deficient mdx mouse using 3D CMR tagging.

Authors:  Wei Li; Wei Liu; Jia Zhong; Xin Yu
Journal:  J Cardiovasc Magn Reson       Date:  2009-10-22       Impact factor: 5.364

9.  Myocardial Fat Imaging.

Authors:  Peter Kellman; Diego Hernando; Andrew E Arai
Journal:  Curr Cardiovasc Imaging Rep       Date:  2010-03-11

10.  Left ventricular T2 distribution in Duchenne muscular dystrophy.

Authors:  Janaka P Wansapura; Kan N Hor; Wojciech Mazur; Robert Fleck; Sean Hagenbuch; D Woodrow Benson; William M Gottliebson
Journal:  J Cardiovasc Magn Reson       Date:  2010-03-18       Impact factor: 5.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.